Studying the Effects of the X10D Shoe on Walking in Healthy Adults Aged 50 to 65

NCT07296913 | Completed

• 1 other identifier: 2025-00477
• Study Type: interventional
• Target: 15
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to characterize the biomechanical effects of the X10D sole using objective, quantitative measurement methods. The walking pattern of many people is becoming increasingly passive, and the muscles of the feet and legs are getting weaker. The X10D shoe is an adapted shoe designed to make walking more active and dynamic again. This study investigates the detailed biomechanical effects of the X10D shoe on the walking pattern of healthy participants. For this purpose, walking with the X10D shoe will be compared with (1) walking in a control shoe with a neutral sole and (2) walking in the participants' everyday sports shoes.

Conditions

Walking; the Immediate and Long-lasting Effects of the X10D Sole on Important Aspects of Walking Function in Healthy Participants

Outcome Measures

Primary Outcomes (1)

• CoP path during ankle-foot roll-over movement as measured by pressure plates integrated in the treadmill

  up to 4 weeks

Study Arms (1)

Interventional shoe

EXPERIMENTAL

Device: X10D shoe

Interventions

X10D shoe DEVICE

In this study, we assess the immediate and long-lasting (3-4 weeks) effects of the X10D shoe on a comprehensive battery of biomechanical parameters during various forms of walking. This will be the first study to provide a detailed characterization of the effects of the X10D shoe on diverse walking parameters in healthy individuals aged 50 to 65 years.

Interventional shoe

Eligibility Criteria

• Age: 50 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Healthy subjects aged 50-65 years
• Ability to walk at minimum 30 minutes at a regular pace without assistance or breaks
• Written informed consent as documented by signature (see informed consent form)

You may not qualify if:

• Women who are pregnant or breast feeding
• Current neurological problems affecting walking function and balance
• Current orthopedic problems affecting upper and lower extremity movements
• History of alcohol abuse or the intake of psychotropic drugs
• History of major cardiac condition (e.g., infarction, insufficiency (NYHA II-IV))
• History of major pulmonary condition (e.g., chronic obstructive pulmonary disease (GOLD II-IV))
• Current major depression or psychosis
• Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia
• Fever of unknown origin

Sponsors & Collaborators

• University of Zurich: lead
• Balgrist Campus AG: collaborator

Study Sites (1)

Balgrist Campus AG

Zurich, Canton of Zurich, 8008, Switzerland

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: BASIC SCIENCE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 27, 2025
• First Posted: December 22, 2025
• Study Start: October 3, 2025
• Primary Completion: December 19, 2025
• Study Completion: December 19, 2025
• Last Updated: January 16, 2026

Record last verified: 2026-01

Locations

CH (1)